- Site-of-care shifts are changing infusion economics. Payers are steering infusion therapy toward lower-cost settings such as home infusion therapy, ambulatory infusion centers and ambulatory infusion sites.
- Reimbursement pressure is driving operational complexity. Providers must navigate site-of-care restrictions, therapy-specific prior authorizations and changing payer rules.
- Administrative burden is increasing. Revenue cycle teams are managing higher prior authorization volumes, manual benefit verification and more documentation-related delays.
- Revenue cycle performance is now strategic. Strong intake, verification, authorization and denial prevention processes can become a competitive advantage.
- Infusion providers need scalable RCM support. As infusion volumes grow, providers need visibility across the revenue cycle to protect reimbursement and support patient access.
The infusion care landscape is evolving rapidly, and one of the biggest drivers of change is the growing shift toward alternate sites of care.
Payers are increasingly steering infusion therapy away from traditional hospital outpatient departments (HOPDs) and toward lower-cost settings, such as home infusion therapy (HIT), ambulatory infusion centers (AICs) and ambulatory infusion sites (AIS). While this shift is often discussed through the lens of patient access and cost savings, the reality is that it is fundamentally reshaping the revenue cycle and reimbursement landscape for infusion providers.
It was a topic that surfaced repeatedly in conversations throughout this year’s NHIA conference: how can providers balance reimbursement pressures, operational complexity and patient experience while continuing to grow?
The Shift Is Being Driven by Reimbursement Pressure
As specialty drug utilization continues to rise, payers are aggressively focused on reducing the total cost of infusion therapy. Lower-cost care settings, like home infusion and AICs, are becoming increasingly attractive alternatives to hospital-based administration.
However, this introduces a new layer of reimbursement complexity for providers.
What used to be a relatively straightforward billing and authorization process now often requires navigating:
- Site-of-care restrictions tied to specific payer policies
- Therapy-specific prior authorization requirements
- Frequent changes in payer reimbursement rules
- Coordination between pharmacy, nursing and billing teams
- Increased documentation requirements to justify medical necessity
Administrative Burden Is Increasing
As providers scale home infusion and alternate-site services, revenue cycle teams are often absorbing the operational strain.
Many organizations are managing:
- Higher volumes of prior authorizations
- Manual benefit verification processes
- Increased denial rates related to site-of-care eligibility
- Delays caused by incomplete documentation
- Longer reimbursement cycles for specialty therapies
Revenue cycle teams are now expected to keep pace with changing authorization rules, varying payer policies by therapy and increased scrutiny around clinical documentation - all while maintaining fast referral turnaround times and supporting a positive patient experience.
This can result in small workflow breakdowns creating significant downstream impacts.
A delayed authorization can postpone therapy start dates, incomplete intake documentation can trigger denials and missed payer requirements can lead to reimbursement delays on high-dollar claims. For infusion providers operating on tight margins, these inefficiencies add up quickly.
Revenue Cycle Performance Has Become a Strategic Advantage
As site-of-care decisions become more financially driven, revenue cycle performance is no longer just an operational function. It has become a strategic differentiator.
Providers that succeed in this environment will be able to operationalize reimbursement workflows efficiently while maintaining strong patient and financial outcomes.
That requires:
- Streamlined intake and referral management
- Efficient insurance verification workflows
- Strong prior authorization processes
- Proactive denial prevention strategies
- Better visibility into reimbursement bottlenecks
- Scalable operational support as infusion volumes grow
Providers are increasingly recognizing that operational efficiency and reimbursement performance are now deeply connected.
Supporting Providers Through the Shift
At Prochant, we work closely with HIT, AIC and AIS providers navigating these evolving reimbursement and operational challenges.
Our focus is on helping providers reduce administrative friction, improve efficiency and gain visibility across the entire revenue cycle, supporting growth and patient access.
As the infusion landscape continues to evolve, providers need RCM partners that understand not just the complexity of infusion reimbursement, but the real-world workflow challenges that come with site-of-care transformation.
Frequently Asked Questions
What does site of care mean in infusion therapy?
Site of care refers to the setting where infusion therapy is delivered. In infusion care, this may include a hospital outpatient department, home infusion therapy, an ambulatory infusion center or an ambulatory infusion site.
Why are payers shifting infusion therapy to alternate sites of care?
Payers are increasingly focused on reducing the total cost of infusion therapy. Lower-cost settings, such as home infusion and ambulatory infusion centers, are becoming more attractive alternatives to hospital-based administration.
How does site-of-care strategy affect infusion reimbursement?
Site-of-care strategy can affect authorization requirements, payer reimbursement rules, documentation expectations and denial risk. Providers may need to navigate therapy-specific prior authorization requirements, site-of-care restrictions and payer-specific policies.
What revenue cycle challenges are caused by site-of-care shifts?
Site-of-care shifts can increase prior authorization volume, manual benefit verification work, documentation requirements, denial risk and reimbursement delays. These challenges can create operational pressure for infusion revenue cycle teams.
How can infusion providers prepare for site-of-care reimbursement changes?
Infusion providers can prepare by strengthening intake and referral management, improving insurance verification workflows, building stronger prior authorization processes, preventing denials earlier and gaining better visibility into reimbursement bottlenecks.
